Comparison of the Diagnostic Yield of Intracoronary Acetylcholine Infusion and Acetylcholine Bolus Injection Protocols During Invasive Coronary Function Testing.

[1]  Dave L Dixon,et al.  2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. , 2023, Circulation.

[2]  M. Beijk,et al.  Meta-analysis and systematic review of coronary vasospasm in ANOCA patients: Prevalence, clinical features and prognosis , 2023, Frontiers in Cardiovascular Medicine.

[3]  K. Node,et al.  JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction. , 2023, Circulation journal : official journal of the Japanese Circulation Society.

[4]  M. Beijk,et al.  Post-spastic flow recovery time to document vasospasm induced ischemia during acetylcholine provocation testing , 2022, International journal of cardiology. Heart & vasculature.

[5]  M. Beijk,et al.  Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index. , 2022, International journal of cardiology.

[6]  M. Beijk,et al.  Haemodynamic characterisation of different endotypes in coronary artery vasospasm in reaction to acetylcholine , 2022, International journal of cardiology. Heart & vasculature.

[7]  M. Beijk,et al.  Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries , 2022, Circulation. Cardiovascular interventions.

[8]  P. Damman,et al.  Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm. , 2022, JACC. Cardiovascular interventions.

[9]  P. Damman,et al.  Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm. , 2021, International journal of cardiology.

[10]  U. Sechtem,et al.  Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing. , 2020, JACC. Cardiovascular interventions.

[11]  P. Noseworthy,et al.  Coronary Endothelial Dysfunction Is Associated With Increased Risk of Incident Atrial Fibrillation , 2020, Journal of the American Heart Association.

[12]  Michael C. McDaniel,et al.  Functional coronary angiography in symptomatic patients with no obstructive coronary artery disease , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  Tomoki Sakaue,et al.  Dose maximal acetylcholine dose into the left coronary artery affect the positive provoked spasm in the left circumflex artery? , 2019, Coronary artery disease.

[14]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[15]  Christopher J. Rush,et al.  Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.

[16]  Michail I. Papafaklis,et al.  Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis. , 2018, Journal of the American College of Cardiology.

[17]  S. Cho,et al.  Gender differences in long-term clinical outcomes and prognostic factors in patients with vasospastic angina. , 2017, International journal of cardiology.

[18]  E. Prescott,et al.  Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries. , 2017, Journal of the American College of Cardiology.

[19]  S. Sueda,et al.  The acetylcholine administration time plays the key role for provoked spasm in the spasm provocation test. , 2017, Journal of cardiology.

[20]  Eun Mi Lee,et al.  Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery. , 2017, Atherosclerosis.

[21]  T. Miyoshi,et al.  Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine , 2015, Heart and Vessels.

[22]  F. Crea,et al.  International standardization of diagnostic criteria for vasospastic angina , 2015, European heart journal.

[23]  Ryotaro Yamada,et al.  Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease , 2015, Circulation.

[24]  J. Kaski,et al.  Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.

[25]  B Milan Horáček,et al.  Difference vectors to describe dynamics of the ST segment and the ventricular gradient in acute ischemia. , 2013, Journal of electrocardiology.

[26]  P. Ganz,et al.  Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. , 2003, Circulation.

[27]  D. Holmes,et al.  Evaluation of patients with minimally obstructive coronary artery disease and angina. , 1996, International journal of cardiology.

[28]  Hiroaki Shimokawa,et al.  International standardization of diagnostic criteria for microvascular angina. , 2018, International journal of cardiology.